Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 1.01x is 95% above its 5-year average of 0.52x, near the low end of its 5-year range (-3.09x–228.45x).
13.37% below its 12-month average of 1.17x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 2.11x.
INTEREST COVERAGE RATIO
1.01x
INTEREST COVERAGE RATIO AVG TTM
1.17x
INTEREST COVERAGE RATIO AVG 3Y
0.53x
INTEREST COVERAGE RATIO AVG 5Y
0.52x
INTEREST COVERAGE RATIO AVG 10Y
50.50x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-13.37%
CURRENT VS 3Y AVG
+91.66%
CURRENT VS 5Y AVG
+95.49%
CURRENT VS 10Y AVG
-98.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+115.84%
vs the sector median at left
ICU Medical, Inc.
Market Cap
$3.95B
Interest Coverage Ratio
1.01x
TTM Avg
1.17x
3Y Avg
0.53x
5Y Avg
0.52x
Market Cap
$4.01B
Interest Coverage Ratio
N/A
TTM Avg
46.33x
3Y Avg
38.87x
5Y Avg
38.87x
Market Cap
$4.04B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.11B
Interest Coverage Ratio
4.05x
TTM Avg
3.05x
3Y Avg
3.05x
5Y Avg
3.05x
Market Cap
$3.74B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.25B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.33B
Interest Coverage Ratio
-4.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.56B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.55B
Interest Coverage Ratio
N/A
TTM Avg
8071.00x
3Y Avg
8071.00x
5Y Avg
8071.00x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ICU Medical, Inc. (ICUI) | $3.95B | 1.01x | 1.17x | 0.53x | 0.52x |
| AbCellera Biologics Inc. (ABCL)vs › | $4.01B | N/A | 46.33x | 38.87x | 38.87x |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.04B | N/A | N/A | N/A | N/A |
| LivaNova PLC (LIVN)vs › | $4.11B | 4.05x | 3.05x | 3.05x | 3.05x |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.74B | N/A | N/A | N/A | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.25B | N/A | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.33B | -4.85x | N/A | N/A | N/A |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.56B | N/A | N/A | N/A | N/A |
| Veracyte, Inc. (VCYT)vs › | $3.55B | N/A | 8071.00x | 8071.00x | 8071.00x |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | -2.80x | N/A | N/A | N/A |
Interest Coverage
1.0x
Debt/Equity
0.59
Current Ratio
2.43
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 2.11x |
| 2026-03-31 | 1.55x |
| 2025-12-31 | 1.02x |
| 2025-09-30 | 0.69x |
| 2025-06-30 | 0.46x |
| 2025-03-31 | 0.44x |
| 2024-12-31 | 1.44x |
| 2024-09-30 | 0.30x |
| 2024-06-30 | 0.29x |
| 2024-03-31 | -0.40x |
| 2023-12-31 | -0.46x |
| 2023-09-30 | 0.88x |
| 2023-06-30 | 0.11x |
| 2023-03-31 | 0.39x |
| 2022-12-31 | -0.01x |
| 2022-09-30 | -0.02x |
| 2022-06-30 | 0.00x |
| 2022-03-31 | -3.09x |
| 2021-12-31 | 65.10x |
| 2021-09-30 | 228.45x |
| 2021-06-30 | 211.47x |
| 2021-03-31 | 165.03x |
| 2020-09-30 | 41.44x |
| 2020-06-30 | 25.36x |
| 2020-03-31 | 132.94x |
| 2019-12-31 | 129.15x |
| 2019-09-30 | 236.68x |
| 2019-06-30 | 188.96x |
| 2019-03-31 | 228.36x |
| 2018-12-31 | -75.42x |
| 2018-09-30 | 2.92x |
| 2018-06-30 | 230.75x |
| 2018-03-31 | 21.72x |
| 2017-12-31 | 136.64x |
| 2017-09-30 | -5.25x |
| 2017-06-30 | -68.44x |
| 2017-03-31 | -33.11x |
| 2016-09-30 | 387.16x |
| 2016-06-30 | 474.38x |
